AN OVERVIEW ON POLYCYSTIC OVARY SYNDROME

A. Mehtaj Begum*, Dr. Mohammed Halith, Shafika Rishmana Sathik Basha, M. Surya, S. Swetha and
S. Syed Shakeel Ahamed

ABSTRACT

Polycystic Ovary Syndrome is the most prevalent endocrine metabolic disorder affecting 6-10% of reproductive aged women worldwide. Women with Polycystic Ovary Syndrome (PCOS) seek health care for 3 major reasons: infertility, menstrual irregularity, and androgen excess. The infertility is associated with anovulation. The condition of menstrual irregularity is generally chronic and such a condition may arise either from the beginning of the menarche or anytime during the reproductive period. Symptoms like amenorrhea and irregular bleeding are the common characteristic feature of anovulation. Androgen excess may be manifested by varying degrees of hirsutism. Patients may also report acne. The rapid development of virilizing signs, such as deepening of the voice, increased muscle mass, and temporal balding, would prompt a person to search for a tumour and would distract her away from a diagnosis of PCOS. Typically the treatments for PCOS are aimed at alleviating the symptoms such as ovulation induction for infertility, oral contraceptives or a progestin for menstrual irregularity, and oral contraceptives or spironolactone for hirsutism. On the basis of recent epidemiologic data which expresses about the increased cardiovascular risk among women with PCOS, such treatment might be complemented by a long-term approach that addresses the underlying pathophysiology of insulin resistance. In the following work we have practiced in hospital for a period of one week to understand the syndrome PCOS and we have collected the possible necessary data for our survey.

Keywords: Polycystic Ovary Syndrome, Puberty, Menstrual cycle, Infertility, Phenotypes, Diagnosis, Treatment and Management.